105 related articles for article (PubMed ID: 16489054)
1. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.
Feigelson HS; Cox DG; Cann HM; Wacholder S; Kaaks R; Henderson BE; Albanes D; Altshuler D; Berglund G; Berrino F; Bingham S; Buring JE; Burtt NP; Calle EE; Chanock SJ; Clavel-Chapelon F; Colditz G; Diver WR; Freedman ML; Haiman CA; Hankinson SE; Hayes RB; Hirschhorn JN; Hunter D; Kolonel LN; Kraft P; LeMarchand L; Linseisen J; Modi W; Navarro C; Peeters PH; Pike MC; Riboli E; Setiawan VW; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D
Cancer Res; 2006 Feb; 66(4):2468-75. PubMed ID: 16489054
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the HSD17B1 gene and risk of prostate cancer.
Kraft P; Pharoah P; Chanock SJ; Albanes D; Kolonel LN; Hayes RB; Altshuler D; Andriole G; Berg C; Boeing H; Burtt NP; Bueno-de-Mesquita B; Calle EE; Cann H; Canzian F; Chen YC; Crawford DE; Dunning AM; Feigelson HS; Freedman ML; Gaziano JM; Giovannucci E; Gonzalez CA; Haiman CA; Hallmans G; Henderson BE; Hirschhorn JN; Hunter DJ; Kaaks R; Key T; Le Marchand L; Ma J; Overvad K; Palli D; Pike MC; Riboli E; Rodriguez C; Setiawan WV; Stampfer MJ; Stram DO; Thomas G; Thun MJ; Travis R; Trichopoulou A; Virtamo J; Wacholder S
PLoS Genet; 2005 Nov; 1(5):e68. PubMed ID: 16311626
[TBL] [Abstract][Full Text] [Related]
3. HSD17B1 genetic variants and hormone receptor-defined breast cancer.
Gaudet MM; Chanock S; Dunning A; Driver K; Brinton LA; Lissowska J; Peplonska B; Pharoah P; Garcia-Closas M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2766-72. PubMed ID: 18843021
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
5. Characterization of HSD17B1 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.
Plourde M; Samson C; Durocher F; Sinilnokova O; Simard J;
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):115-28. PubMed ID: 18083510
[TBL] [Abstract][Full Text] [Related]
6. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Garcia-Closas M
Cancer Res; 2006 Oct; 66(19):9781-5. PubMed ID: 17018638
[TBL] [Abstract][Full Text] [Related]
8. Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.
Obazee O; Justenhoven C; Winter S; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Hannelius U; Li J; Humphreys K; Hall P; Giles G; Severi G; Baglietto L; Southey M; Rabstein S; Harth V; Lotz A; Pesch B; Brüning T; Baisch C; Ko YD; Hamann U; Brauch H
Breast Cancer Res Treat; 2013 Apr; 138(2):543-8. PubMed ID: 23430226
[TBL] [Abstract][Full Text] [Related]
9. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
10. Amplification of HSD17B1 and ERBB2 in primary breast cancer.
Gunnarsson C; Ahnström M; Kirschner K; Olsson B; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
Oncogene; 2003 Jan; 22(1):34-40. PubMed ID: 12527905
[TBL] [Abstract][Full Text] [Related]
11. A systematic assessment of common genetic variation in CYP11A and risk of breast cancer.
Setiawan VW; Cheng I; Stram DO; Giorgi E; Pike MC; Van Den Berg D; Pooler L; Burtt NP; Le Marchand L; Altshuler D; Hirschhorn J; Henderson BE; Haiman CA
Cancer Res; 2006 Dec; 66(24):12019-25. PubMed ID: 17178901
[TBL] [Abstract][Full Text] [Related]
12. HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore.
Wu AH; Seow A; Arakawa K; Van Den Berg D; Lee HP; Yu MC
Int J Cancer; 2003 Apr; 104(4):450-7. PubMed ID: 12584742
[TBL] [Abstract][Full Text] [Related]
13. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
Haiman CA; Dossus L; Setiawan VW; Stram DO; Dunning AM; Thomas G; Thun MJ; Albanes D; Altshuler D; Ardanaz E; Boeing H; Buring J; Burtt N; Calle EE; Chanock S; Clavel-Chapelon F; Colditz GA; Cox DG; Feigelson HS; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn JN; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Le Marchand L; Lenner P; Lund E; Panico S; Peeters PH; Pike MC; Riboli E; Tjonneland A; Travis R; Trichopoulos D; Wacholder S; Ziegler RG
Cancer Res; 2007 Mar; 67(5):1893-7. PubMed ID: 17325027
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M;
Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421
[TBL] [Abstract][Full Text] [Related]
16. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.
Freedman ML; Penney KL; Stram DO; Le Marchand L; Hirschhorn JN; Kolonel LN; Altshuler D; Henderson BE; Haiman CA
Hum Mol Genet; 2004 Oct; 13(20):2431-41. PubMed ID: 15317758
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.
Olson JE; Ingle JN; Ma CX; Pelleymounter LL; Schaid DJ; Pankratz VS; Vierkant RA; Fredericksen ZS; Wu Y; Couch FJ; Vachon CM; Sellers TA; Weinshilboum RM
Breast Cancer Res Treat; 2007 Apr; 102(2):237-47. PubMed ID: 17004113
[TBL] [Abstract][Full Text] [Related]
18. Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates.
Feigelson HS; McKean-Cowdin R; Coetzee GA; Stram DO; Kolonel LN; Henderson BE
Cancer Res; 2001 Jan; 61(2):785-9. PubMed ID: 11212283
[TBL] [Abstract][Full Text] [Related]
19. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
20. The impact of germline genetic variations in hydroxysteroid (17-beta) dehydrogenases on prostate cancer outcomes after prostatectomy.
Audet-Walsh É; Bellemare J; Lacombe L; Fradet Y; Fradet V; Douville P; Guillemette C; Lévesque É
Eur Urol; 2012 Jul; 62(1):88-96. PubMed ID: 22209174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
